Growth Of Prescription Drugs Spending Slowing, But That Won’t Necessarily Be Reflected For Consumers

“We’re not suggesting that nobody is seeing higher costs," said Murray Aitken, of the IQVIA Institute for Human Data Science, which released the numbers. "We’re just saying that when we roll everything up, the amount received by manufacturers rose by only 0.6 percent in 2017.”

from Kaiser Health News https://ift.tt/2K2teL4